OcuPair, a Novel Photo‐crosslinkable PAMAM Dendrimer‐Hyaluronic Acid Hydrogel Bandage/Bioadhesive for Corneal Injuries and Temporary Corneal Repair
Advanced Science · 2025-06 · 12 (23)
DOI: 10.1002/advs.202417731 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 27.03.2025. Verfasst von Siva P Kambhampati und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Nanomedicine, Wilmer Eye Institute, Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Hauptthemen laut MEDLINE: Corneal Injuries, Hyaluronic Acid, Dendrimers, Hydrogels. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: U.S. Army Military Health System (USAMMDA-TCR), Foundation Fighting Blindness.
Abstract (Originalsprache)
Traumatic corneal injuries are a leading cause of blindness among military personnel. These injuries need immediate attention in the combat zone, but treatment options are limited as life‐saving measures are often prioritized. To address this critical gap, we have developed OcuPair TM , a two‐component hydrogel system that consists of i) an injectable viscoelastic filler that stabilizes the ocular cavity and prevents hypotony. ii) An in situ photo‐curable adhesive hydrogel comprising of methacrylated, hydroxyl PAMAM dendrimer and hyaluronic acid engineered to form a transparent, flexible, and robust bandage within 90 seconds, adhering to the corneal surface and ensuring a water‐tight seal securing full‐thickness corneal wounds. Ex vivo studies demonstrated that the adhesive hydrogel is mechanically robust and withstands intraocular pressures beyond physiological range. In a rabbit corneal injury model, OcuPair TM effectively sealed complex full‐thickness wounds and preserved the eye with favorable clinical outcomes for 5 days with no toxicity over 30 days. In this study, we have validated the pilot scale synthesis, formulation optimization, GMP scale‐up, and IDE‐enabling GLP toxicity, essential for clinical translation as a battlefield‐ready solution.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Nanomedicine, Wilmer Eye Institute, Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
- Ashvattha Therapeutics, Inc., Baltimore, MD, USA.
ORCID-Profile: Siva P Kambhampati, Rishi Sharma, Jeffrey L Cleland, Rangaramanujam M Kannan
Förderung
- U.S. Army Military Health System (USAMMDA-TCR)
- Foundation Fighting Blindness
Zitieren
APA
Kambhampati, S. P., Sharma, R., Lin, H., Appiani, S., Cleland, J. L., Yiu, S. C., & Kannan, R. M. (2025). OcuPair, a Novel Photo‐crosslinkable PAMAM Dendrimer‐Hyaluronic Acid Hydrogel Bandage/Bioadhesive for Corneal Injuries and Temporary Corneal Repair. Advanced Science, 12(23). https://doi.org/10.1002/advs.202417731
Vancouver
Kambhampati SP, Sharma R, Lin H, Appiani S, Cleland JL, Yiu SC, et al. OcuPair, a Novel Photo‐crosslinkable PAMAM Dendrimer‐Hyaluronic Acid Hydrogel Bandage/Bioadhesive for Corneal Injuries and Temporary Corneal Repair. Advanced Science. 2025;12(23). doi:10.1002/advs.202417731
BibTeX
@article{Kambhampati2025,
author = {Kambhampati, Siva P and Sharma, Rishi and Lin, Hui and Appiani, Santiago and Cleland, Jeffrey L and Yiu, Samuel C and Kannan, Rangaramanujam M},
title = {OcuPair, a Novel Photo‐crosslinkable PAMAM Dendrimer‐Hyaluronic Acid Hydrogel Bandage/Bioadhesive for Corneal Injuries and Temporary Corneal Repair},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {23},
doi = {10.1002/advs.202417731}
}
EUVIMED